Gleevec, a brand of imatinib mesylate, is used in the treatment of Chronic Myeloid Leukemia, a rare form of cancer.

Related categories 1

Gleevec
Imatinib mesylate. Features prescribing and reimbursement information for US residents.
Gleevec Information
Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert.
Imatinib ( Glivec ) - International Site
Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
Life Raft Group
Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer.
MedlinePlus: Imatinib
Features information about dosage, usage, warnings, and side effects.
Last update:
November 19, 2015 at 5:24:02 UTC
Health
Home
News
Recreation
Reference
Regional
Science
Shopping
Society
Sports
All Languages
Arts
Business
Computers
Games